Fig. 6.
Biological peculiarities of the two subtypes. A Differential expression analysis for transcriptomes between the two subtypes. B-C Proteomaps demonstrating functional analysis in B ZHPS1 and C ZHPS2 based on the KEGG database. D-F GO enrichment analysis for D biological process, E cellular component and F molecular function. G Differences in Hallmark pathways through GSVA between ZHPS2 and ZHPS1. H GSEA of the Reactome pathways (ZHPS2 versus ZHPS1). I-K Estimated IC50 values of I abiraterone, J docetaxel and K olaparib